Navigation Links
Commonly used medications associated with impaired physical function in older adults
Date:5/3/2008

WINSTON-SALEM, N.C. Older adults who take drugs designed to block the neurotransmitter acetylcholine including common medications for incontinence, high blood pressure and allergies are more likely to be dependent in one or more activities of daily living and to walk slower, according to new findings from researchers at Wake Forest University School of Medicine and colleagues.

The findings, which involve a class of drugs known as anticholinergic medications, are from the Ginkgo Evaluation of Memory Study (GEMS) and will be presented at the American Geriatrics Society Meeting in Washington, D.C., on May 3.

These results were true even in older adults who have normal memory and thinking abilities, said Kaycee M. Sink, M.D., M.A.S., lead author. For older adults taking a moderately anticholinergic medication, or two or more mildly anticholinergic medications, their function was similar to that of someone three to four years older.

In a separate study reported this month in the Journal of the American Geriatrics Society, Sink found that older nursing home residents who took medications for dementia and anticholingeric medications for incontinence at the same time had a 50 percent faster decline in function than those who were being treated only for dementia.

Over a years time, the decline would represent a resident going from requiring only limited assistance in an activity to being completely dependent, or from requiring only supervision to requiring extensive assistance in an activity.

Sink said that the two studies together suggest that physicians should carefully consider the implications when prescribing anticholingeric medications to older adults.

Because these medications are so commonly prescribed, older adults who take multiple medications are at increased risk of taking one or more anticholinergic-containing medications, said Sink. The potential effects on physical function represent a significan
'/>"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
2. New U of C research examines commonly used toxin
3. Cells on path to becoming mature T-cells more flexible than commonly thought
4. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
5. Diet and medications may assist prevention of prostate cancer
6. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
7. Patients cant recall their medications to tell doctors
8. The American Pharmacists Association Supports Consumer Education About OTC Medications
9. Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis
10. Many Osteoporosis Medications Prevent Fractures, But None Is Proven Best
11. Cost of glaucoma medications may impact treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...swire/--TheBayAreaAirQualityManagementDistrictisis...r Alert forThursday,November26,2009whichbansb...,bothindoorsandoutdoors. ,, "Cold,stillweatherw...ckBroadbent,executiveofficeroftheAirDistrict."We,r...ighborsandfellowcommunitymembersthisThanksgiving,a...
(Date:11/25/2009)...ar cancer who were treated with cisplatin-based ch... neurological side effects and Raynaud-like phenom...py, according to a new study published online Nove...titute . , Marianne Brydy, M.D., of the Departme...Bergen, Norway, and colleagues conducted a cross-s...
(Date:11/25/2009)...rew out of a collaboration between UCLA engineers ... nearly 10 million Americans who suffer from perip...ening of the arteries, peripheral arterial disease... narrowed arteries reduce blood flow to the limbs....ar disease, heart attack and stroke, and its progr...
(Date:11/25/2009)...o short to draw definite conclusions, experts say,...) -- In diabetic patients with blocked coronary ar...mes at one year whether patients undergo bypass su...chers report. , Bypass surgery has been the sta...y artery disease. However, less invasive approache...
(Date:11/25/2009)...ion and treatment clinics to resume Monday, Nov. 3...ember 25, 2009 -- Centegra Health System is contin... shots at four Centegra Primary Care (CPC) vaccina... arrived. The clinics are at CPC sites in Huntley,...pen as follows: ,   From 4:30 to 7:30 ...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...g battle against cancer, researchers of Virginia h...destiny. Radiation therapy is used to treat many t...py makes cancer cells more susceptible to radiatio...t-Ullrich, of Virginia Commonwealth University in ...
...with a new technique of removing cancerous kidneys...ands and a special camera and instuments. This is ... be done in significantly less time than the stand...sity of Michigan(U-M) Health System, U.S., may hel...
...ty of New South Wales have identified a toxin that...disease of Alzheimer’s in the elderly population. ... of quinolinic acid neurotoxicity in the brains of...earch paper, which is, published in the current is...
...xplore the link between alcohol and certain type o...tic factors //that influence DNA repair pathways. ..., a suspected carcinogen (a substance that can ind...neficial to the body because they have been shown ...
...mother.There is no substitute to her milk’ // . ...e to the efforts of WHO, UNICEF and breast feedin... respectable practice. As the ‘World Breastfe...ountries. While in some countries it applauds the ...
...ty of Buffalo had said that postmenopausal women w...hey can keep their periodontal disease at bay. The...ournal of Periodontology.// Researchers who h...t alveolar bone loss is one of the most important ...
Other Medicine News:Health News:Gene enchances radiation therapy - A novel approach to fight cancer 2Health News:Making operation and recovery time shorter 2Health News:Toxin Identified For Alzheimer’s Diseas 2Health News:New Insight In Periodontal Disease In Postmenopausal Women 2
(Date:11/25/2009)...,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.toda...efexecutiveofficer,willpresentatthePiperJaffray21s...,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fern...antibioticclinicalprogramsforthetreatmentofdrug-re...harmaceuticals ,, Foundedin2006,CempraPharmace...
(Date:11/25/2009)...lif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,annou...,sPROTECT-1(theProspectiveRandomizedOralTherapyEva...282-B)inpatientswithmoderate-to-severeCrohn,sdisea...andtolerabilityprofile.Thestudydemonstratedevidenc...asdefinedasa70-pointdecreaseintheCrohn,sDiseaseAct...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--Vermillion,Inc.(VRML...ofReorganizationandDisclosureStatementtoday,Novemb...DistrictofDelaware.Ahearingtoconsiderapprovalofthe...8,2009,withthehearingontheconfirmationofthePlansch...mpanytopayallclaimsinfull.ThePlanisexpected,ifappr...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3NeurogesX to Present at Upcoming Fall Conferences 13797 1NeurogesX to Present at Upcoming Fall Conferences 13797 2NeurogesX to Present at Upcoming Fall Conferences 13797 3NeurogesX to Present at Upcoming Fall Conferences 13797 4MarketsandMarkets 3A Global Biosimilars Product Market Worth 2419 4 Billion by 2014 13795 1MarketsandMarkets 3A Global Biosimilars Product Market Worth 2419 4 Billion by 2014 13795 2MarketsandMarkets 3A Global Biosimilars Product Market Worth 2419 4 Billion by 2014 13795 3Scientists Make Sweet Monkey Music 55988 1Scientists Make Sweet Monkey Music 55988 2
...ent Medical - SECRITT I Study to Evaluate Preventi...ening Vulnerable Plaques, ROTTERDAM, Netherlands ...rdiology team led by Professor Patrick W. Serruys,...in the left anterior,descending (LAD) coronary art... in Rotterdam. This case marks the start of a pilo...
...e II Trial Shows Increase in Mature Dendritic Cell...aceuticals today confirmed that results of a Phase...the Journal of Clinical Oncology. The,study showed...ian overall,survival of 65 months and increased ma...s. Dendritic cells are special antigen-presenting ...
Other Medicine Technology:Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial 2Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial 3Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 2Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 3Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 4Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma 5
Retinal Rake Spatula Pick: 130mm Long, Standard
Guibor bubble comforter
AfterCare Eye Bandages
NitEye The Dry Eye Comforter
Medicine Products: